Report Detail
Global (United States, European Union and China) Blood Plasma Market Research Report 2019-2025
- RnM3608993 |
- 22 July, 2019 |
- Global |
- 110 Pages |
- QYResearch |
- Pharma & Healthcare
Plasma is the liquid portion of the blood. Plasma is the versatile component and makes about 55% of the blood. Plasma is the composite mixture of more than 700 proteins and other substances which are vital for the efficient functioning of the human body. Plasma helps in regulating body temperature and blood pressure. It serves as a medium for exchange of proteins, nutrients and hormones to the different parts of the body. Clotting factor, albumin and immunoglobulin are some of the major proteins found in plasma. Plasma is extracted as proteins and substances and used as main ingredients in medical products to replace body fluids, clotting factors and antibodies. Plasma is used as a component for the treatment of serious health problems such as hemophilia and autoimmune disorders.
North America dominates the global market for blood plasma due to large number of aging population. Asia followed by the Europe is expected to show high growth rates in the next five years in global blood plasma market. China is expected to be the fastest growing blood plasma markets in Asia region. Some of the key driving forces for blood plasma market in emerging countries are large pool of patients and rising government funding.
In 2019, the market size of Blood Plasma is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Blood Plasma.
This report studies the global market size of Blood Plasma, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Blood Plasma sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Baxter International
CSL
Grifols
Octapharma
ADMA Biologics
Cerus Corp
Sanquin
Shanghai Raas
TCS Biosciences
Market Segment by Product Type
Immunoglobulin
Albumin
Protease Inhibitors
Coagulation Factor Concentrates
Others
Market Segment by Application
Hospitals and Clinics
Research Laboratories
Academic Institutions
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Blood Plasma status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Blood Plasma manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Blood Plasma are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Blood Plasma Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Immunoglobulin
- 1.3.3 Albumin
- 1.3.4 Protease Inhibitors
- 1.3.5 Coagulation Factor Concentrates
- 1.3.6 Others
- 1.4 Market Segment by Application
- 1.4.1 Global Blood Plasma Market Share by Application (2019-2025)
- 1.4.2 Hospitals and Clinics
- 1.4.3 Research Laboratories
- 1.4.4 Academic Institutions
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Blood Plasma Market Size
- 2.1.1 Global Blood Plasma Revenue 2014-2025
- 2.1.2 Global Blood Plasma Sales 2014-2025
- 2.2 Blood Plasma Growth Rate by Regions
- 2.2.1 Global Blood Plasma Sales by Regions 2014-2019
- 2.2.2 Global Blood Plasma Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Blood Plasma Sales by Manufacturers
- 3.1.1 Blood Plasma Sales by Manufacturers 2014-2019
- 3.1.2 Blood Plasma Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Blood Plasma Revenue by Manufacturers (2014-2019)
- 3.2.2 Blood Plasma Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Blood Plasma Market Concentration Ratio (CR5 and HHI)
- 3.3 Blood Plasma Price by Manufacturers
- 3.4 Key Manufacturers Blood Plasma Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Blood Plasma Market
- 3.6 Key Manufacturers Blood Plasma Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Immunoglobulin Sales and Revenue (2014-2019)
- 4.1.2 Albumin Sales and Revenue (2014-2019)
- 4.1.3 Protease Inhibitors Sales and Revenue (2014-2019)
- 4.1.4 Coagulation Factor Concentrates Sales and Revenue (2014-2019)
- 4.1.5 Others Sales and Revenue (2014-2019)
- 4.2 Global Blood Plasma Sales Market Share by Type
- 4.3 Global Blood Plasma Revenue Market Share by Type
- 4.4 Blood Plasma Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Blood Plasma Sales by Application
6 United States
- 6.1 United States Blood Plasma Breakdown Data by Company
- 6.2 United States Blood Plasma Breakdown Data by Type
- 6.3 United States Blood Plasma Breakdown Data by Application
7 European Union
- 7.1 European Union Blood Plasma Breakdown Data by Company
- 7.2 European Union Blood Plasma Breakdown Data by Type
- 7.3 European Union Blood Plasma Breakdown Data by Application
8 China
- 8.1 China Blood Plasma Breakdown Data by Company
- 8.2 China Blood Plasma Breakdown Data by Type
- 8.3 China Blood Plasma Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Blood Plasma Breakdown Data by Company
- 9.2 Rest of World Blood Plasma Breakdown Data by Type
- 9.3 Rest of World Blood Plasma Breakdown Data by Application
- 9.4 Rest of World Blood Plasma Breakdown Data by Countries
- 9.4.1 Rest of World Blood Plasma Sales by Countries
- 9.4.2 Rest of World Blood Plasma Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Baxter International
- 10.1.1 Baxter International Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Blood Plasma
- 10.1.4 Blood Plasma Product Introduction
- 10.1.5 Baxter International Recent Development
- 10.2 CSL
- 10.2.1 CSL Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Blood Plasma
- 10.2.4 Blood Plasma Product Introduction
- 10.2.5 CSL Recent Development
- 10.3 Grifols
- 10.3.1 Grifols Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Blood Plasma
- 10.3.4 Blood Plasma Product Introduction
- 10.3.5 Grifols Recent Development
- 10.4 Octapharma
- 10.4.1 Octapharma Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Blood Plasma
- 10.4.4 Blood Plasma Product Introduction
- 10.4.5 Octapharma Recent Development
- 10.5 ADMA Biologics
- 10.5.1 ADMA Biologics Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Blood Plasma
- 10.5.4 Blood Plasma Product Introduction
- 10.5.5 ADMA Biologics Recent Development
- 10.6 Cerus Corp
- 10.6.1 Cerus Corp Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Blood Plasma
- 10.6.4 Blood Plasma Product Introduction
- 10.6.5 Cerus Corp Recent Development
- 10.7 Sanquin
- 10.7.1 Sanquin Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Blood Plasma
- 10.7.4 Blood Plasma Product Introduction
- 10.7.5 Sanquin Recent Development
- 10.8 Shanghai Raas
- 10.8.1 Shanghai Raas Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Blood Plasma
- 10.8.4 Blood Plasma Product Introduction
- 10.8.5 Shanghai Raas Recent Development
- 10.9 TCS Biosciences
- 10.9.1 TCS Biosciences Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Blood Plasma
- 10.9.4 Blood Plasma Product Introduction
- 10.9.5 TCS Biosciences Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Blood Plasma Sales Channels
- 11.2.2 Blood Plasma Distributors
- 11.3 Blood Plasma Customers
12 Market Forecast
- 12.1 Global Blood Plasma Sales and Revenue Forecast 2019-2025
- 12.2 Global Blood Plasma Sales Forecast by Type
- 12.3 Global Blood Plasma Sales Forecast by Application
- 12.4 Blood Plasma Forecast by Regions
- 12.4.1 Global Blood Plasma Sales Forecast by Regions 2019-2025
- 12.4.2 Global Blood Plasma Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Blood Plasma. Industry analysis & Market Report on Blood Plasma is a syndicated market report, published as Global (United States, European Union and China) Blood Plasma Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Blood Plasma market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
